Nav: Home

Current Lung cancer News and Events

Current Lung cancer News and Events, Lung cancer News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Pathogen engineered to self-destruct underlies cancer vaccine platform
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. (2019-06-24)
New p53 gene discovery sheds light on how to make cancer therapies more effective
Scientists at VCU Massey Cancer Center have discovered that the loss of a protein called DBC1 in breast cancer cells leads to the dysregulation of normal anti-cancer functions, contributing to cancer cell growth and resistance to therapies. (2019-06-20)
Long thought harmless, a glycan biomarker may cause pancreatic disease and cancer
A widely recognized biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may in fact be a promoter for the development of these diseases, including pancreatic cancer. (2019-06-20)
Researchers find cause of rare, fatal disease that turns babies' lips and skin blue
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. (2019-06-19)
Study reveals global disparities in cervical cancer rates among women with HIV
A new International Journal of Cancer study indicates that rates of invasive cervical cancer (ICC) are particularly high in women living with HIV in South Africa or Latin America. (2019-06-19)
Cell division at high speed
When two proteins work together, this worsens the prognosis for lung cancer patients: their chances of survival are particularly poor in this case. (2019-06-18)
Innovative technique uses sensory nanoparticles to detect disease
Like dipping a donut hole in powdered sugar, nanoparticles collect a unique coating of proteins from the blood. (2019-06-17)
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified. (2019-06-17)
Lumping all Hispanic Americans together masks the differences in cancer outcomes
When separated out, the data can help tailor better screening and treatment programs, especially for stomach and liver cancers. (2019-06-17)
Tiny probe that senses deep in the lung set to shed light on disease
A hair-sized probe that can measure key indicators of tissue damage deep in the lung has been developed by scientists. (2019-06-16)
CNIO researchers find effective drug combinations for glioblastoma in mice
Glioblastoma is a brain tumour with very poor prognosis. Patients with glioblastoma usually develop resistance to treatments. (2019-06-13)
Early release rules for prisoners at end of life may be 'discriminatory,' say doctors
Doctors are calling for reform to rules governing when terminally ill prisoners are suitable for early release on compassionate grounds (ERCG) amid concerns that the current approach is discriminatory. (2019-06-12)
Determining risk of recurrence in triple-negative breast cancer
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, Ph.D., researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah. (2019-06-12)
Cancer survivors predicted to number over 22 million by 2030
There were more than 16.9 million Americans with a history of cancer on Jan. (2019-06-11)
Researchers reveal key role of pressure-sensing protein in lung edema
Researchers at the University of Illinois at Chicago describe for the first time the role of a unique, pressure-sensing protein in the development of lung edema -- a condition in which chronic high vascular pressure in the lungs causes fluid from the bloodstream to enter the air spaces of the lungs. (2019-06-11)
Radiation treatment increases cardiac risk for lung cancer patients
As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure. (2019-06-10)
New radiotracer can identify nearly 30 types of cancer
A novel class of radiopharmaceuticals has proven effective in non-invasively identifying nearly 30 types of malignant tumors. (2019-06-07)
Normal tissues not so normal, but instead mosaics of mutated cells
Normal cell populations may not be as 'normal' as once thought; rather, tissues contain lineages of mutational mosaics developed over a lifetime, according to a comprehensive RNA sequence analysis of more than 6,700 samples across 29 different human tissues. (2019-06-06)
Researchers spot mutations that crop up in normal cells as we age
Cell division is not perfect. As we get older, mutations often appear in genes in normal cells. (2019-06-06)
Listening to music eases pain and other symptoms in patients with breast cancer
A European Journal of Cancer Care study found that listening to music at home reduced the severity of symptoms, pain intensity, and fatigue experienced by patients with breast cancer. (2019-06-05)
Biomarker predicts which pancreatic cysts may become cancerous
A multicenter team led by investigators at Washington University School of Medicine in St. (2019-06-05)
Combating undetected lung inflammation in patients with an autoimmune disorder
An observational study involving 50 patients with APECED -- a genetic autoimmune disorder -- has demonstrated that targeting T and B cell activity combats a serious lung-related complication often overlooked or misdiagnosed in patients with the condition. (2019-06-05)
Zebrafish capture a 'window' on the cancer process
Cancer-related inflammation impacts significantly on cancer development and progression. New research has observed in zebrafish, for the first time, that inflammatory cells use weak spots or micro-perforations in the extracellular matrix barrier layer to access skin cancer cells. (2019-06-04)
Heart disease deaths nearly halved in a decade -- but condition remains UK's biggest killer
A new analysis of global heart disease deaths has revealed the number of UK people dying from the condition halved between 2005 and 2015, with the death rate falling from 80 deaths per 100,000 to 46 per 100,000. (2019-06-04)
Bid to beat superbugs boosted by immune defence discovery
The fight against superbugs could be helped by the discovery of a potential therapy based on the body's natural immune defences. (2019-06-03)
NCI-MATCH trial finds the combination of dabrafenib and trametinib effective
Findings from NCI-MATCH Arm H, orally presented on Monday, June 3rd at the ASCO 2019 annual meeting in Chicago, show that in a heavily pre-treated cohort of 17 distinct tumor types -- several rare -- with BRAF mutations, the combination of dabrafenib and trametinib showed promising activity outside of currently approved FDA indications. (2019-06-03)
Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response (MPR) rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery. (2019-06-03)
UT Southwestern develops test to predict immunotherapy response in kidney cancer
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy. (2019-06-03)
Immunotherapy drug found safe in treating cancer patients with HIV
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA. (2019-06-03)
Chest cavity fire during emergency cardiac surgery
At this year's Euroanaesthesia Congress (the annual meeting of the European Society of Anaesthesiology) in Vienna, Austria (1-3 June), doctors present the unique case of a man who suffered a flash fire in his chest cavity during emergency heart surgery caused by supplemental oxygen leaking from a ruptured lung. (2019-06-02)
NRG oncology trial of metformin for non-small cell lung cancer
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC). (2019-06-01)
Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer according to interim results of a large, multicenter trial. (2019-05-31)
Occupational hazards account for more than one in ten people with range of lung diseases
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine. (2019-05-31)
International travelers experience the harmful effects of air pollution
Even a short stay for travelers in cities with high levels of air pollution leads to breathing problems that can take at least a week from which to recover, a new study shows. (2019-05-30)
Annual Report to the Nation: Overall cancer mortality continues to decline
For all cancer sites combined, cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016. (2019-05-30)
Significant 'knowledge gap' exists in use of genetic testing to decide cancer treatment
A survey conducted by Georgetown investigators found a significant knowledge and practice gap among community oncologists in the understanding and usage of genetic testing in determining patients' treatment plans and potential clinical trial outcomes. (2019-05-30)
ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer
Median time to treatment discontinuation (TTD) on crizotinib was 8.8 months; TTD of patients using entrectinib was 14.6 months. (2019-05-30)
ASCO: Oncologists see benefit of medical marijuana, but not comfortable prescribing
73 percent of oncology providers believe that medical marijuana provides benefits for cancer patients, but only 46 percent are comfortable recommending it. (2019-05-30)
ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors
University of Colorado Cancer Center study presented at ASCO 2019 shows that brigatinib remains effective even after treatment with another next-generation ALK inhibitor (2019-05-30)
Early genome catastrophes can cause non-smoking lung cancer
Catastrophic rearrangements in the genome occurring as early as childhood and adolescence can lead to the development of lung cancer in later years in non-smokers. (2019-05-30)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...